Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy
Clinical Infectious Diseases · 04.03.2023 · 76 (5) · 930-933
DOI: 10.1093/cid/ciac828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 18.10.2022. Verfasst von Kelly A Johnson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV-1, HIV Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIAID NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59–20.14; P = .007). This suggests an existing point-of-care assay developed for tenofovir disoproxil fumarate will support adherence monitoring for patients on all TFV-based antiretrovirals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of California San Francisco, San Francisco, California, USA.
- Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Kelly A Johnson
Förderung
- NIMH NIH HHS
- NIAID NIH HHS
- National Institute of Mental Health
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Johnson, K. A., Okochi, H., Arreguin, M., Watabe, J., Glidden, D. V., Chattopadhyay, A., Imbert, E., Hickey, M. D., Gandhi, M., & Spinelli, M. (2023). Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy. Clinical Infectious Diseases, 76(5), 930-933. https://doi.org/10.1093/cid/ciac828
Vancouver
Johnson KA, Okochi H, Arreguin M, Watabe J, Glidden DV, Chattopadhyay A, et al. Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy. Clinical Infectious Diseases. 2023;76(5):930-933. doi:10.1093/cid/ciac828
BibTeX
@article{Johnson2023,
author = {Johnson, Kelly A and Okochi, Hideaki and Arreguin, Mireya and Watabe, Joseph and Glidden, David V and Chattopadhyay, Anindita and Imbert, Elizabeth and Hickey, Matthew D and Gandhi, Monica and Spinelli, Matthew},
title = {Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {76},
number = {5},
pages = {930--933},
doi = {10.1093/cid/ciac828}
}
EUVIMED